Advertisement

Topics

Interview: Fledgling ABL Bio And Its Global Ambitions In Bispecific Antibodies

03:14 EDT 17 Aug 2017 | SCRIP

South Korea’s ABL Bio is tackling cancer and neurodegenerative diseases with its broad bispecific antibody pipeline and CEO Sang Hoon...

      

Related Stories

 

Original Article: Interview: Fledgling ABL Bio And Its Global Ambitions In Bispecific Antibodies

NEXT ARTICLE

More From BioPortfolio on "Interview: Fledgling ABL Bio And Its Global Ambitions In Bispecific Antibodies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...